Language selection

Search

Patent 2962092 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2962092
(54) English Title: SYSTEM FOR THE TRANSCUTANEOUS DETERMINATION OF THE BLOOD ALCOHOL CONCENTRATION
(54) French Title: SYSTEME DE DETERMINATION DE LA CONCENTRATION D'ALCOOL DANS LE SANG PAR VOIE TRANSCUTANEE
Status: Granted and Issued
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61B 5/1455 (2006.01)
  • A61B 5/00 (2006.01)
  • A61B 5/145 (2006.01)
(72) Inventors :
  • MORLEY, STEFAN (Germany)
  • TROELLSCH, ARNE (Germany)
  • FORNASIERO, LIVIO (Germany)
(73) Owners :
  • DRAEGER SAFETY AG & CO. KGAA
(71) Applicants :
  • DRAEGER SAFETY AG & CO. KGAA (Germany)
(74) Agent: FIELD LLP
(74) Associate agent:
(45) Issued: 2019-07-23
(86) PCT Filing Date: 2015-09-24
(87) Open to Public Inspection: 2016-04-14
Examination requested: 2017-03-22
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP2015/001902
(87) International Publication Number: WO 2016055141
(85) National Entry: 2017-03-22

(30) Application Priority Data:
Application No. Country/Territory Date
102014014872.6 (Germany) 2014-10-06

Abstracts

English Abstract


A system for the transcutaneous measurement of the concentration of a
substance,
preferably alcohol, in blood is shown and described, said system having a
light source
(1); a detector device (15); an optical device (7, 7'), which has an inlet
(5), an outlet (49)
and an exit opening (35); and a contact surface element (37) with a contact
surface (41),
wherein the contact surface element (37) is arranged such that measuring
radiation
exiting leaving the exit opening (35) falls through the contact surface
element (37),
wherein the contact surface (41) is provided on the side of the contact
surface element
(37) facing away from the optical device (7, 7'). wherein the inlet (5) of the
optical device
(7, 7') is arranged such that measuring radiation emitted by the light source
(1) reaches
the inlet (5) of the optical device (7, 7'), wherein the optical device (7,
7') is configured
such that measuring radiation emitted by the light source (1) and entering the
inlet (5)
exits through the exit opening (35) and is focused in a measuring point (39)
on the side of
the contact surface element (37) facing away from the optical device (7, 7')
at a
predefined distance from the contact surface (41), wherein the optical device
(7, 7') is
configured such that scattered radiation generated in the measuring point (39)
and
entering into the exit opening (35) is focused in an outlet point (19) at the
outlet (49), and
wherein the detector device (15) is arranged such that it detects scattered
radiation
focused at the outlet point (19).


French Abstract

L'invention concerne un système permettant de mesurer la concentration d'une substance, de préférence d'alcool, dans le sang, comportant une source lumineuse (1), un dispositif de détection (15), un système optique (7, 7') présentant une entrée (5), une sortie (49) et une ouverture de sortie (35), et un élément (37) de surface d'appui présentant une surface d'appui (41). L'élément (37) de surface d'appui est agencé de telle manière que le rayonnement de mesure sortant par l'ouverture de sortie (35) traverse l'élément (37) de surface d'appui, la surface d'appui (41) étant située sur le côté de l'élément (37) de surface d'appui opposé au système optique (7, 7'). L'entrée (5) du système optique (7, 7') est agencée de telle manière que le rayonnement de mesure émis par la source lumineuse (1) atteint l'entrée (5) du système optique (7, 7'), le système optique (7, 7') étant configuré de telle manière que le rayonnement de mesure émis par la source lumineuse (1) et entrant par l'entrée (5) sort par l'ouverture de sortie (35) et est focalisé en un point de mesure (39) à une distance prescrite de la surface d'appui (41) sur le côté de l'élément (37) de surface d'appui opposé au système optique (7, 7'). Le système optique (7, 7') est configuré de telle manière que le rayonnement diffus produit au point de mesure (39) et entrant dans l'ouverture de sortie (35) est focalisé en un point de sortie (19) au niveau de la sortie (49), l'unité de détection (15) étant agencée de telle manière qu'elle détecte le rayonnement diffus focalisé au niveau du point de sortie (19).

Claims

Note: Claims are shown in the official language in which they were submitted.


CLAIMS
1. A system for a transcutaneous measurement of a concentration of a
substance
in blood of a subject, the system comprising:
a light source configured to emit a measuring radiation;
a detector device configured to detect a scattered radiation;
an optical device with an inlet, an outlet aperture and an exit opening
aperture,
and a contact surface element with a contact surface,
wherein:
the contact surface element is arranged such that measuring radiation exiting
the
exit opening falls through the contact surface element;
the contact surface is provided on a side of the contact surface element
facing
away from the optical device;
the inlet of the optical device is arranged such that measuring radiation
emitted by
the light source falls on the inlet of the optical device;
the optical device is configured such that measuring radiation emitted by the
light
source and entering the inlet exits through the exit opening aperture and is
focused in a
measuring point on the side of the contact surface element facing away from
the optical
device at a predefined distance from the contact surface;
the optical device is configured such that scattered radiation generated at
the
measuring point and entering the exit opening aperture is focused in an outlet
point at the
outlet aperture;
the optical device is configured confocally with the outlet point and the
measuring
point both focused at the same predefined distance from the contact surface
and with the
outlet aperture limiting scattered radiation generated outside the predefined
distance from
passing therethrough and the exit opening aperture limiting scattered
radiation generated
outside the predefined distance from passing therethrough and the exit opening
aperture
limiting measuring radiation that is directed outside the predefined distance
from passing
13

therethrough;
the detector device is arranged such that the detector device detects the
scattered
radiation focused at the outlet point; and
the detector device comprises a grating spectrometer, a Fabry-Perot
interferometer
or a Fourier transformation spectrometer.
2. A system in accordance with claim 1, wherein the detector device is set
up to
output a spectrum of at least part of the detected scattered radiation.
3. A system in accordance with claim 1 or 2. wherein the detector device is
configured to bring about the spectral resolution of the scattered radiation
in a
wavelength range of 0.7 µm to 3.5 µm.
4. A system in accordance with any one of claims 1 to 3, wherein the
optical device
has an outlet element, which focuses the measuring radiation exiting the exit
opening
aperture into the measuring point.
5. A system in accordance with claim 4, wherein the outlet element is
configured as
a convergent lens and wherein a focal point of the convergent lens coincides
with the
measuring point.
6. A system in accordance with claim 4, wherein the outlet element is
configured as
a spherical, elliptical or parabolic outlet mirror and wherein a focal point
of the outlet
mirror coincides with the measuring point.
7. A system in accordance with claim 1, wherein the optical device has a
focusing
element, which converts the scattered radiation generated in the measuring
point and
falling in through the outlet aperture into a parallel ray bundle, wherein the
optical device
14

has a semitransparent mirror, which is arranged such that the parallel ray
bundle falls on the
mirror and is partially reflected to the outlet aperture, and measuring
radiation falling in
through the inlet falls onto the focusing element through the mirror.
8. A system in accordance with claim 1, wherein the optical device has a
focusing
element, which converts scattered radiation generated in the measuring point
and falling
in through the outlet aperture into a parallel ray bundle, wherein the optical
device has a first
convergent lens device and a second convergent lens device, wherein the first
and second
convergent lens devices are arranged such that the parallel ray bundle falls
on the first and
second convergent lens devices, wherein a focal point of the first convergent
lens device, which
focal point is located on a side of the first convergent lens device facing
away from the focusing
element, forms the inlet of the optical device, and wherein the focal point of
the second
convergent lens device, which is located on a side of the second convergent
lens device facing
away from the focusing element, forms the focal point of the optical device.
9. A system in accordance with claim 7 or 8, wherein the focusing element
is
configured as a convergent lens device.
10. A system in accordance with any one of claims 1 to 9, wherein a
distance of the
measuring point from the contact surface, measured at right angles to the
contact surface, is
between 0.1 mm and 3 mm.
11. A system in accordance with any one of claims 1 to 10, wherein the
light source
generates measuring radiation in an infrared or near infrared range.
12. A system in accordance with claim 11, wherein the light source has a
laser and a
doped emitter element.

13. A system in accordance with claim 11, wherein the light source has a
laser and a
doped light guide.
14. A system in accordance with claim 1 or 2, wherein the detector device
is
configured to bring about the spectral resolution of the scattered radiation
in a
wavelength range of 1.3 µm to 2.5 µm.
15. A system in accordance with any one of claims 1 to 9, wherein a
distance of the
measuring point from the contact surface. measured at right angles to the
contact surface. is
between 0.5 mm and 1 mm.
16. A system in accordance with any one of claims 1 to 15, further
comprising a
computer connected to both the light source and the detector device and
configured to
actuate the light source and the detector device and configured to analyze a
spectra signal output
by the detector device.
17. A system in accordance with claim 16, wherein the computer is
configured to analyze the spectra signal output by the detector device to
determine a
concentration of alcohol based on the spectra signal output.
18. A system in accordance with claim 17, the computer is configured to
analyze
absorption bands of the spectra signal output by the detector device in a
wavelength range of 0.7
µm to 3.5 µm.
16

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02962092 2017-03-22
SYSTEM FOR THE TRANSCUTANEOUS DETERMINATION OF
THE BLOOD ALCOHOL CONCENTRATION
FIELD OF THE INVENTION
The present invention pertains to a system for transcutaneous determination of
the
concentration of a substance, preferably alcohol, in the blood.
BACKGROUND OF THE INVENTION
The blood alcohol concentration of test subjects has hitherto been determined,
especially
during traffic stops, invasively by taking blood. The common measurement
methods are
chromatography and the ADH method (alcohol dehydrogenase method). Blood must
be
taken from the test subject in both cases, and the blood is then analyzed
according to the
corresponding principle. These methods are therefore comparatively time-
consuming
and, in particular, not suitable for stops, in which the result is needed
immediately. In
particular, such methods cannot be used with so-called interlocks in motor
vehicles which
only enable the vehicle to be started if it was determined before that blood
alcohol
concentration of the driver does not exceed a predefined limit value.
Methods have therefore been developed in which the breath alcohol
concentration is
determined. Using conversion methods, the alcohol content can be inferred from
the
breath alcohol concentration. However, the problem arises in this connection
that the test
subject must blow breathing air into opening for measuring the breath alcohol
concentration, which is first associated with hygienic problems. This can be
solved by
1

CA 02962092 2017-03-22
using a new, cleaned mounted for the measuring device for each test subject.
This is,
however, associated, in turn, with considerable efforts.
Finally, the method of determining the blood alcohol concentration optically
transcutaneously, i.e., through the skin of the test subject, was developed in
the recent
past as an injury-free, non-invasive method for determining the blood alcohol
concentration. Light of the near or middle infrared range is radiated here
into the
patient's skin and the scattered light is analyzed spectrally for absorption
bands of the
alcohol. However, this has the technical problem that the topmost layer of the
skin,
namely, the epidermis, is not vascularized by blood vessels or is vascularized
to a very
low extent only, so that an optical measurement, which is sensitive to this
topmost layer,
can only yield inaccurate measured values only because of the high signal-to-
noise ratio.
Only the deeper dermis and the subcutaneous tissue contain sufficient
quantities of blood
vessels, so that signals that make it possible to determine the blood alcohol
concentration
in a reliable manner can be obtained here. This means that a measuring
radiation that can
penetrate the skin deeper than 1 mm and preferably up to 3 mm must be used, so
that
scattered radiation is generated in the desired areas.
To further increase the accuracy of the measurement, it is desirable to limit
the depth
range in which the measurement is sensitive.
SUMMARY OF THE INVENTION
Based on the state of the art, the object of the present invention is
therefore to provide a
system for the transcutaneous determination of the concentration of a
substance in the
2

CA 02962092 2017-03-22
blood and especially for determining the blood alcohol concentration, which
has a simple
configuration and can yield measurement results with a higher accuracy.
According to the present invention, this object is accomplished by a system
with a light
source, which is configured to emit a measuring radiation, with a detector
device, which
is configured to detect the scattered radiation, with an optical device, which
has an inlet,
an outlet and an exit opening, and with a contact surface element with a
contact surface,
wherein the contact surface element is arranged such that measuring radiation
exiting
from the exit opening falls through the contact surface element, wherein the
contact
.. surface is provided on the side of the contact surface element facing away
from the
optical device, wherein the inlet of the optical device is arranged such that
measuring
radiation emitted by the light source falls on the inlet of the optical
device, wherein the
optical device is configured such that measuring radiation emitted from the
light source
and entering the inlet exits through the exit opening and is focused in a
measuring point
on the side of the contact surface element facing away from the optical device
at a
predefined distance from the contact surface, wherein the optical device is
configured
such that scattered radiation generated in the measuring point entering the
exit opening is
focused in an outlet point at the outlet, and wherein the detector device is
arranged such
that it detects the scattered radiation focused at the outlet point.
For example, the blood alcohol concentration of a test subject can be
determined with the
system according to the present invention as follows. A body part of the test
subject, e.g.,
the arm, is first arranged on the contact surface of the contact surface
element adjacent to
the exit opening. Measuring radiation emitted from the light source and
falling on the
inlet of the optical device then exits from the exit opening and falls on the
skin of the
patient. The measuring radiation is focused by a measuring point, which is
located at a
3

CA 02962092 2017-03-22
spaced location from the contact surface and hence also at a spaced location
from the skin
surface. This measuring point is preferably at a depth between 0.1 mm and 3
mm,
especially preferably between 0.5 mm and 1 mm under the skin surface and is
thus
located at a spaced location from the contact surface. At the same time, the
optical
device is configured according to the present invention such that scattered
radiation
generated at this measuring point is focused in an outlet point at the outlet
of the optical
device.
Due to the detector device being arranged in the outlet point or due to an
optical
connection of the device to this outlet point via a light guide, this makes it
possible to
limit the area within the skin of the test subject, to which the detector
device is sensitive,
to the area around the measuring point.
Thus, the optical device is configured in the measuring system according to
the present
invention confocally in the sense that the outlet point and the measuring
point are focused
at the same time in the skin of the test subject.
The scattered radiation, which is focused in the outlet point and was
generated essentially
in the measuring point, is detected by the detector device and can be
correspondingly
analyzed to determine the concentration of the substance in question in the
blood. This
can preferably be carried out by the detector device being set up to output a
spectrum of
at least part of the detected scattered radiation. Such a spectrum can be
analyzed for
absorption bands of the substance in question, i.e., for example, alcohol. It
is also
conceivable, as an alternative, that the emitted spectra are compared to
spectra being
stored in a storage device and the blood alcohol concentration is calculated
from this.
4

CA 02962092 2017-03-22
The detector device may have a grating spectrometer or a Fabry-Perot
interferometer for
this purpose. It is advantageous in respect to the determination of the blood
alcohol
concentration if the detector device is configured to bring about the spectral
resolution of
the scattered radiation in the range of a wavelength of 0.7 m to 3.5 m and
preferably
1.3 pm to 2.5 pm.
The optical device may have, adjacent to or directly in the exit opening, an
inlet element,
which focuses the measuring radiation exiting from the exit opening into the
measuring
point. This outlet element may be configured as a convergent lens, with the
focal point of
this convergent lens coinciding with the measuring point It is also possible
as an
alternative that the outlet element is configured as a spherical or parabolic
outlet mirror,
whose focal point now coincides with the measuring point.
In a preferred embodiment, the optical device may have a focusing element, for
example,
in the form of a convergent lens, which converts scattered radiation generated
in the
measuring point and falling in through the outlet element into a parallel ray
bundle, the
optical device having a semitransparent mirror, which is arranged such that
the parallel
ray bundle falls on the mirror and is partially reflected to the outlet and
that measuring
radiation falling in through the inlet of the optical device falls through the
focusing
element. Due to this configuration, it is achieved in the optical device in a
simple manner
that the measuring radiation is focused in the measuring point, on the one
hand, and that
the scattered radiation generated there reaches the outlet point, on the other
hand, the
measuring radiation and the scattered radiation run partially along the same
optical path.
As an alternative, the optical device may have a focusing element, configured,
e.g., as a
convergent lens, which converts scattered radiation generated in the measuring
point and
5

CA 02962092 2017-03-22
falling through the outlet element into a parallel ray bundle, wherein the
optical device
has a first convergent lens device and a second convergent lens device,
wherein the first
convergent lens device and the second convergent lens device are arranged such
that the
parallel ray bundle falls on the first and second convergent lens devices,
wherein the
focal point of the first convergent lens device, which is located on the side
of the first
collector lens device facing away from the focusing element, forms the inlet
of the optical
device, and wherein the focal point of the second convergent lens device,
which is
located on the side of the convergent lens device facing away from the
focusing element,
forms the outlet point of the optical device. It is achieved in a simple
manner that the
measuring radiation and the scattered radiation can extend partially along the
same path
in this embodiment as well.
Finally, it is advantageous for determining the blood alcohol concentration if
the light
source generates measuring radiation in the infrared or near infrared range.
This can be
achieved, for example, by a laser, which irradiates a doped emitter element.
In addition,
it is conceivable that the light source has a laser and a doped light guide,
via which the
laser is connected to the inlet of the optical device.
BRIEF DESCRIPTION OF THE DRAWINGS
The present invention will be explained below on the basis of a drawing
showing an
exemplary embodiment, which is only a preferred exemplary embodiment. In the
drawings:
Figure 1 is a schematic view showing a first exemplary embodiment of a system
according to the present invention;
6

CA 02962092 2017-03-22
Figure 2 is a schematic view showing a second exemplary embodiment of a system
according to the present invention;
Figure 3a is a schematic view showing one of two forms of light sources for
exemplary
embodiments from Figures 1 and 2; and
Figure 3b is a schematic view showing another of two forms of light sources
for
exemplary embodiments from Figures 1 and 2.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Figure 1 shows a first exemplary embodiment of a system according to the
present
invention for the transcutaneous measurement of the blood alcohol
concentration. The
system has a light source 1, which is connected to the inlet 5 of an optical
device 7 by
means of a light guide 3. The light source 1 is configured to emit a measuring
radiation,
the radiation in the exemplary embodiments being described here being
radiation from
the near infrared range, i.e., the wavelengths are between 0.7 gm and 3 gm.
To achieve this, the light source 1, as is shown in part a) of Figure 3, may
have a laser 9,
which irradiates an emitter 11, which is, in turn, coated with a ceramic
powder. This may
be doped with Nd, Yb, Er, Tm, Ho, Cr, Co or Ti, which causes the emitter 11 to
emit
infrared radiation in the above-mentioned wavelength range. As an alternative,
the light
source 1 may also be configured, as is shown in part b) of Figure 3, in such a
manner that
the radiation of a laser 9 is coupled into a doped light guide 13, said light
guide 13 being
able to be doped with the elements mentioned in connection with the emitter
11.
7

CA 02962092 2017-03-22
The system shown in Figure 1 has, in addition, a detector device 15, in front
of which a
lens device 17 is arranged such that scattered radiation focused by the
optical device 7 in
an outlet point 19 is further focused onto the detector device 15, so that
this can detect the
scattered radiation. The detector device 15 is configured such that it emits a
spectrum of
at least one part of the detected scattered radiation. The detector device 15
may be
configured here as a grating spectrometer or as a Fabry-Perot interferometer
or as a
Fourier transformation spectrometer (FTS or FTIR in English). In addition, the
detector
device 15 is able to bring about the spectral resolution of the scattered
radiation in a
wavelength range of 0.7 um to 3.5 um and preferably 1.3 pm to 2.5 p.m.
Both the light source 1 and the detector device 15 are connected to a computer
21, so that
both the light source 1 and the detector device 15 can be actuated by the
computer 21 and
the computer 21 can analyze the spectra emitted by the detector device 15.
The optical device 7 has a convergent lens 23, which is directed towards the
inlet 5 and
whose focal point coincides with the inlet 5, so that measuring radiation
arriving from the
light source 1 is converted into an essentially parallel ray bundle, which
will then fall on
a focusing element likewise configured as a convergent lens 27 through a
semitransparent
mirror 25. The measuring radiation is focused further by the convergent lens
27 and is
sent by means of a light guide 29 to the focal point of a first spherical or
elliptical or
parabolic mirror 31. The radiation exiting from the first mirror 31 falls on a
second
spherical or elliptical or parabolic mirror 33, which acts as an outlet
element or outlet
mirror and focuses the measuring radiation through an exit opening 35 and a
contact
surface element 37 of the optical device 7 into a measuring point 39. On the
side facing
away from the optical device 7, the contact surface element 37 has a contact
surface 41,
with which a body part 43, shown only schematically, can be in contact such
that it is
8

CA 02962092 2017-03-22
located opposite the exit opening 35. The second mirror 33 is arranged
relative to the
contact surface 41 such that the measuring point 39 lies on the side of the
contact surface
element 37 facing away from the optical device 7 at a predefined distance from
the
contact surface 41. It is achieved due to this configuration that the
measuring point 39, in
which the measuring radiation is focused, is located at a distance from the
surface of the
body part 43 when the latter is in contact with the contact surface 41. The
distance
between the measuring point 39 and the contact surface 41, measured at right
angles to
the contact surface 41, is preferably between 0.1 mm and 3 mm and especially
preferably
between 0.5 mm and 1 mm.
When the light source 1 emits measuring radiation, this falls through the exit
opening 35
and is focused, as was already described, in the measuring point 39 at a
distance from the
skin surface of the body part 43 of a test subject, so that characteristic
scattered radiation
is generated especially in the area of the measuring point 39. This scattered
radiation
passes back into the optical device 7 through the exit opening 35, is focused
through the
mirrors 31, 33 and sent to the focal point 45 of the convergent lens 27 by
means of the
light guide 29. The scattered radiation is converted by the focusing element
configured
as a convergent lens 27 into a parallel ray bundle and it falls onto the
semitransparent
mirror 25, which casts a part of the scattered radiation to another convergent
lens 47.
This convergent lens 47 focuses the scattered radiation into the outlet point
19 arranged
in an outlet 49 of the optical device 7, where the scattered radiation is
detected by the
detector device 15 in the already described manner.
The measuring radiation is thus focused in this exemplary embodiment in a
point located
at a spaced location from the skin surface, so that essentially the radiation
generated there
is analyzed. This point or the corresponding distance from the contact surface
can be
9

CA 02962092 2017-03-22
selected to be such that the measuring radiation is focused where a sufficient
density of
blood vessels is present, i.e., the dermis or the subcutaneous tissue, so that
a signal
sufficient for the concentration measurement of a substance in the blood is
generated, i.e.,
absorption bands are identified in the scattered radiation or the
concentration in question
of a substance in the blood can be determined by comparison of measured
spectra.
At the same time, the optical device 7 is configured such that precisely the
scattered
radiation generated in the measuring point 39 is focused in the outlet point
19 and is thus
detected by the detector device 15, while precisely scattered radiation
generated at other
depths is not collected in this point but can hardly pass through the outlet
49' acting as a
diaphragm. It is thus ensured that the system is adapted for the blood alcohol
concentration measurement by selecting the distance of the measuring point 39
from the
contact surface 41 and high accuracy can be reached.
Figure 2 shows a second exemplary embodiment of a system according to the
present
invention, in which elements that correspond to elements from the first
exemplary
embodiment, are designated by identical reference numbers.
A light source 1, which may be configured as described in connection with
Figure 3, is
.. likewise provided in this second exemplary embodiment. The light source 1
is connected
via a light guide 3 to the inlet 5 of an optical device 7'. In addition, this
exemplary
embodiment also has a detector device 15, which may be configured as described
in the
first exemplary embodiment. The detector device 15 may consequently be
configured
especially as a grating spectrometer or a Fabry-Perot interferometer and bring
about the
spectral resolution of the wavelength range of 0.7 Jim to 3.5 pm and
preferably 1.3 j.im to
2.5 i_tm. A lens device 17 is, in turn, arranged in front of the detector
device 15 such that

CA 02962092 2017-03-22
scattered radiation focused by the optical device 7' is further focused onto
the detector
device 15 in a point 19' at the outlet 49 of the optical device 7', so that
this [detector
device 15] can detect the scattered radiation.
The light source 1 and the detector device 15 are connected to a computer 21
here as
well, so that this can actuate the light source 1 and perform the further
analysis of the
spectra of the scattered radiation, which are sent by the detector device 15.
The inlet 5 of the optical device 7' is located in the focal point of a first
convergent lens
51, so that the incident measuring radiation is cast by the first convergent
lens 51 as an
essentially parallel ray bundle onto a focusing element likewise configured as
a
convergent lens 27. The convergent lens 27 or the focusing element is also the
outlet
element of the optical device 7' in this exemplary embodiment and it focuses
the
measuring radiation, so that it falls through an exit opening 35 and a contact
surface
element 37. The measuring radiation is focused by the convergent lens 27 in a
measuring
point 39 in this case as well, and said measuring point is located at a
predefined distance
from the contact surface 41 on the side of the contact surface element 37
facing away
from the optical device 7'. In case of a body part 43 being in contact with
the contact
surface 41, the measuring point 39 is thus located at a spaced location from
the skin
surface, and this distance is preferably between 0.1 mm and 3 mm and
preferably
between 0.5 mm and 1 mm.
Scattered radiation generated in the area of the measuring point 39 falls
through the exit
opening 35 back into the optical device 7' and is converted by the convergent
lens 27 into
a parallel ray bundle. In addition, the optical device 7' has a second
convergent lens 53,
on which falls, just as on the first convergent lens 51, the parallel
scattered radiation
11

CA 02962092 2017-03-22
bundle generated by the outlet or focusing element configured as a convergent
lens 27.
The second convergent lens 53 focuses the parallel radiation bundle into the
outlet point
19 of the optical device 7', which outlet point 19 represents the focal point,
and is sent
from here by means of a light guide 55 to the point 19, at which it is
detected by the
.. detector device 15. The focal point of the second convergent lens 53, which
is located on
the side of the second convergent lens 53 facing away from the focusing
element, thus
forms the outlet point 19' of the optical device 7'.
Thus, the optical device 7' of this second exemplary embodiment is also
configured such
that scattered radiation generated in the measuring point 39 and entering the
exit opening
35 is focused in an outlet point 19 or 19' at the outlet 49.
It is thus also achieved in the second exemplary embodiment that the measuring
radiation
is focused in a measuring point 39 located at a spaced location from the
contact surface
.. 41 and only the scattered radiation from the area of the measuring point 39
is focused in
the outlet point 19 and 19' and detected by the detector device 15. Therefore,
this
exemplary embodiment is also sensitive only at a depth predetermined by the
outlet
element or the convergent lens 27, at a spaced location from the skin surface
of the test
subject.
12

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Maintenance Fee Payment Determined Compliant 2024-09-16
Maintenance Request Received 2024-09-16
Common Representative Appointed 2019-10-30
Common Representative Appointed 2019-10-30
Grant by Issuance 2019-07-23
Inactive: Cover page published 2019-07-22
Pre-grant 2019-05-24
Inactive: Final fee received 2019-05-24
Notice of Allowance is Issued 2018-12-21
Notice of Allowance is Issued 2018-12-21
Letter Sent 2018-12-21
Inactive: Office letter 2018-12-21
Inactive: Approved for allowance (AFA) 2018-12-14
Inactive: QS passed 2018-12-14
Amendment Received - Voluntary Amendment 2018-07-26
Interview Request Received 2018-02-12
Inactive: S.30(2) Rules - Examiner requisition 2018-02-01
Inactive: Report - No QC 2018-01-29
Inactive: Cover page published 2017-08-31
Inactive: First IPC assigned 2017-04-19
Inactive: Acknowledgment of national entry - RFE 2017-04-11
Inactive: Acknowledgment of national entry - RFE 2017-04-04
Application Received - PCT 2017-03-30
Inactive: IPC assigned 2017-03-30
Inactive: IPC assigned 2017-03-30
Letter Sent 2017-03-30
Inactive: IPC assigned 2017-03-30
National Entry Requirements Determined Compliant 2017-03-22
Amendment Received - Voluntary Amendment 2017-03-22
Request for Examination Requirements Determined Compliant 2017-03-22
All Requirements for Examination Determined Compliant 2017-03-22
Application Published (Open to Public Inspection) 2016-04-14

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2018-09-13

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Request for examination - standard 2017-03-22
Basic national fee - standard 2017-03-22
MF (application, 2nd anniv.) - standard 02 2017-09-25 2017-09-12
MF (application, 3rd anniv.) - standard 03 2018-09-24 2018-09-13
Final fee - standard 2019-05-24
MF (patent, 4th anniv.) - standard 2019-09-24 2019-09-16
MF (patent, 5th anniv.) - standard 2020-09-24 2020-09-16
MF (patent, 6th anniv.) - standard 2021-09-24 2021-09-17
MF (patent, 7th anniv.) - standard 2022-09-26 2022-09-14
MF (patent, 8th anniv.) - standard 2023-09-25 2023-09-11
MF (patent, 9th anniv.) - standard 2024-09-24 2024-09-16
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
DRAEGER SAFETY AG & CO. KGAA
Past Owners on Record
ARNE TROELLSCH
LIVIO FORNASIERO
STEFAN MORLEY
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 2017-03-22 4 122
Description 2017-03-22 11 486
Abstract 2017-03-22 1 36
Drawings 2017-03-22 3 28
Description 2017-03-23 12 462
Claims 2017-03-23 4 122
Abstract 2017-03-23 1 33
Cover Page 2017-05-08 1 58
Representative drawing 2017-05-08 1 3
Claims 2018-07-26 4 143
Abstract 2018-12-21 1 33
Representative drawing 2019-06-26 1 7
Cover Page 2019-06-26 2 58
Confirmation of electronic submission 2024-09-16 3 75
Acknowledgement of Request for Examination 2017-03-30 1 187
Notice of National Entry 2017-04-04 1 202
Notice of National Entry 2017-04-11 1 202
Reminder of maintenance fee due 2017-05-25 1 112
Commissioner's Notice - Application Found Allowable 2018-12-21 1 163
Amendment / response to report 2018-07-26 14 472
Voluntary amendment 2017-03-22 19 696
Amendment - Abstract 2017-03-22 2 117
National entry request 2017-03-22 4 121
International search report 2017-03-22 2 61
Declaration 2017-03-22 1 56
Maintenance fee payment 2017-09-12 1 26
Examiner Requisition 2018-02-01 4 232
Interview Record with Cover Letter Registered 2018-02-12 1 27
Courtesy - Office Letter 2018-12-21 2 66
Final fee 2019-05-24 1 33